Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer

Kapoor, Avnish, Yao, Wantong, Ying, Haoqiang, Hua, Sujun, Liewen, Alison, Wang, Qiuyun, Zhong, Yi, Wu, Chang-Jiun +22 more·2014·Cell

DOI 10.1016/j.cell.2014.06.003

Cited by (717)

Items 201–300 of 717

The cornerstone K-RAS mutation in pancreatic adenocarcinoma: From cell signaling network, target genes, biological processes to therapeutic targeting
Nicolas Jonckheere, Romain Vasseur, Isabelle VAN SEUNINGEN · 2017 · Critical Reviews in Oncology/Hematology
Drugging the Undruggable: Advances on RAS Targeting in Cancer
Míriam Molina‐Arcas, Amit Samani, Julian Downward · 2021 · Genes
Obesity and Pancreatic Cancer: Insight into Mechanisms
Guido Eibl, Enrique Rozengurt · 2021 · Cancers
Tumor matrix stiffness provides fertile soil for cancer stem cells
Sadegh Safaei, Roya Sajed, Ahmad Shariftabrizi, Shima Dorafshan, Leili Saeednejad Zanjani, Masoumeh Dehghan Manshadi, Zahra Madjd, Roya Ghods · 2023 · Cancer Cell International
Recent Therapeutic Approaches to Modulate the Hippo Pathway in Oncology and Regenerative Medicine
Evan Barry, Vladimir Simov, Iris Valtingojer, Olivier Venier · 2021 · Cells
Oncogenic KRAS signaling and YAP1/β-catenin: Similar cell cycle control in tumor initiation
Ruth Nussinov, Chung‐Jung Tsai, Hyunbum Jang, Tamás Korcsmáros, Péter Csermely · 2016 · Seminars in Cell and Developmental Biology
Targeting KRAS: The Elephant in the Room of Epithelial Cancers
Valeria Merz, Marina Gaule, Camilla Zecchetto, Alessandro Cavaliere, Simona Casalino, Camilla Pesoni, Serena Contarelli, Fabio Sabbadini, Monica Bertolini, Domenico Mangiameli et al. · 2021 · Frontiers in Oncology
Autocrine IGF1 Signaling Mediates Pancreatic Tumor Cell Dormancy in the Absence of Oncogenic Drivers
Rajbhandari, Nirakar, Lin, Wan-chi, Wehde, Barbara L., Triplett, Aleata A., Wagner, Kay-Uwe · 2017 · Cell Reports
Overexpression of TREM2 enhances glioma cell proliferation and invasion: a therapeutic target in human glioma
Xiaoqiang Wang, Bangbao Tao, Bin Li, Xuhui Wang, Wenchuan Zhang, Liang Wan, Xuming Hua, Shiting Li · 2015 · Oncotarget
Insulin Receptor and GPCR Crosstalk Stimulates YAP via PI3K and PKD in Pancreatic Cancer Cells
Hao Fang, Qinhong Xu, Yinglan Zhao, Jan V. Stevens, Steven H. Young, James W. Sinnett‐Smith, Enrique Rozengurt · 2017 · Molecular Cancer Research
Induction of store-operated calcium entry (SOCE) suppresses glioblastoma growth by inhibiting the Hippo pathway transcriptional coactivators YAP/TAZ
Zhijun Liu, Yiju Wei, Lei Zhang, Patricia P. Yee, Martin Johnson, Xuexin Zhang, Melissa Gulley, Jennifer M. Atkinson, Mohamed Trebak, Hong‐Gang Wang et al. · 2018 · Oncogene
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
Richard Francis Dunne, Aram F. Hezel · 2015 · Hematology/Oncology Clinics of North America
YAP Regulates S-Phase Entry in Endothelial Cells
Zhewei Shen, Ben Z. Stanger · 2015 · PLoS ONE
Cdc6 as a novel target in cancer: Oncogenic potential, senescence and subcellular localisation
Nicholas Lim, Paul A. Townsend · 2020 · International Journal of Cancer
Exploiting cancer’s drinking problem: regulation and therapeutic potential of macropinocytosis
Joseph Puccini, Michael A. Badgley, Dafna Bar‐Sagi · 2021 · Trends in cancer
Response and Resistance to RAS Inhibition in Cancer
Richard Y. Ebright, Julien Dilly, Alice Tsang Shaw, Andrew J. Aguirre · 2025 · Cancer Discovery
ERK and p38 MAPK Activities Determine Sensitivity to PI3K/mTOR Inhibition via Regulation of MYC and YAP
Taru E. Muranen, Laura M. Selfors, Julie Hwang, Lisa L. Gallegos, Jonathan L. Coloff, Carson C. Thoreen, Seong Anthony Woo Kang, David M. Sabatini, Gordon Brent Mills, Joan S. Brugge · 2016 · Cancer Research
Hippo signaling is intrinsically regulated during cell cycle progression by APC/C Cdh1
Wantae Kim, Yong Suk Cho, Xiaohui Wang, Ogyi Park, Xueyan Ma, Hanjun Kim, Wenjian Gan, Eek‐hoon Jho, Boksik Cha, Yun-ji Jeung et al. · 2019 · Proceedings of the National Academy of Sciences
The Myb-MuvB Complex Is Required for YAP-Dependent Transcription of Mitotic Genes
Grit Pattschull, Susanne Walz, Marco Gründl, Melissa Schwab, Eva Rühl, Apoorva Baluapuri, Anita Cindric Vranesic, Susanne Kneitz, Elmar Wolf, Carsten Patrick Ade et al. · 2019 · Cell Reports
Machine-Learning and Chemicogenomics Approach Defines and Predicts Cross-Talk of Hippo and MAPK Pathways
Pham, Trang H., Hagenbeek, Thijs J., Lee, Ho-June, Li, Jason, Rose, Christopher M., Lin, Eva, Yu, Mamie, Martin, Scott E., Piskol, Robert, Lacap, Jennifer A. et al. · 2021 · Cancer Discovery
SGLT2 promotes pancreatic cancer progression by activating the Hippo signaling pathway via the hnRNPK-YAP1 axis
Dianyun Ren, Yan Sun, Dan Zhang, Dan Li, Zhiqiang Liu, Xin Jin, Heshui Wu · 2021 · Cancer Letters
The tumour microenvironment in pancreatic cancer — new clinical challenges, but more opportunities
Heng‐Chung Kung, Kevin Zheng, Jacquelyn W. Zimmerman, Lei Zheng · 2025 · Nature Reviews Clinical Oncology
Progress in targeting RAS with small molecule drugs
Frank P. McCormick · 2019 · Biochemical Journal
Targeting the Hippo pathway in cancer
Kieran F. Harvey, Tracy Tzu-Ling Tang · 2025 · Nature Reviews Drug Discovery
A novel brain tumour model in zebrafish reveals the role of YAP activation in MAPK/PI3K induced malignant growth
Marie Mayrhofer, Victor Gourain, Markus Reischl, Pierre Affaticati, Arnim Jenett, Jean‐Stéphane Joly, Matteo Benelli, Francesca Demichelis, Pietro Luigi Poliani, Dirk Sieger et al. · 2016 · Disease Models & Mechanisms
Direct targeting of oncogenic RAS mutants with a tumor-specific cytosol-penetrating antibody inhibits RAS mutant–driven tumor growth
Seungmin Shin, Ji‐Sun Kim, Seong-Wook Park, Sei-Yong Jun, Hye-Jin Kweon, Dong-Ki Choi, Dakeun Lee, Yong Beom Cho, Yong‐Sung Kim · 2020 · Science Advances
Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma
Yu-Huei Liu, Chun‐Mei Hu, Yuan-Sheng Hsu, Wen‐Hwa Lee · 2022 · Cell Death and Disease
Role of Yes-associated protein in cancer: An update
Ramazan Abylkassov, Yingqiu Xie · 2016 · Oncology Letters
Supervised Discriminative Sparse PCA for Com-Characteristic Gene Selection and Tumor Classification on Multiview Biological Data
Chun-Mei Feng, Yong Dong Xu, Jin‐Xing Liu, Ying-Lian Gao, Chun-Hou Zheng · 2019 · IEEE Transactions on Neural Networks and Learning Systems
Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic Cancer
Raffaela Santoro, Marco Zanotto, Francesca Simionato, Camilla Zecchetto, Valeria Merz, Chiara Cavallini, Geny Piro, Fabio Sabbadini, Federico Boschi, Aldo Scarpa et al. · 2019 · Molecular Cancer Therapeutics
YAP1 Mediates Resistance to MEK1/2 Inhibition in Neuroblastomas with Hyperactivated RAS Signaling
Coggins, Grace E., Farrel, Alvin, Rathi, Komal S., Hayes, Colin M., Scolaro, Laura, Rokita, Jo Lynne, Maris, John M. · 2019 · Cancer Research
Emerging Principles in the Transcriptional Control by YAP and TAZ
Alejandro Lopez-Hernandez, Silvia Sberna, Stefano Campaner · 2021 · Cancers
Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway
Chu Zhu, Xinyan Ji, Haitao Zhang, Qi Zhou, Xiaolei Cao, Mei Tang, Yuan Si, Huan Yan, Li Li, Tingbo Liang et al. · 2017 · Journal of Biological Chemistry
YAP Mediates Tumorigenesis in Neurofibromatosis Type 2 by Promoting Cell Survival and Proliferation through a COX-2–EGFR Signaling Axis
William Guerrant, Smitha Kota, Scott A. Troutman, Vinay Mandati, Mohammad Fallahi, Anat O Stemmer-Rachamimov, Joseph L. Kissil · 2016 · Cancer Research
The NDR/LATS protein kinases in immunology and cancer biology
Ahmad A.D. Sharif, Alexander Hergovich · 2017 · Seminars in Cancer Biology
Targeting the Mevalonate Pathway to Overcome Acquired Anti-HER2 Treatment Resistance in Breast Cancer
Vidyalakshmi Sethunath, Huizhong Hu, Carmine De Angelis, Jamunarani Veeraraghavan, Lanfang Qin, Nicholas Wang, Lukas Mikolaj Simon, Tao Wang, Xiaoyong Fu, Agostina Nardone et al. · 2019 · Molecular Cancer Research
KRAS: Biology, Inhibition, and Mechanisms of Inhibitor Resistance
Ash, Leonard J., Busia-Bourdain, Ottavia, Okpattah, Daniel, Kamel, Avrosina, Liberchuk, Ariel, Wolfe, Andrew L. · 2024 · Current Oncology
Lipophilic statins inhibit YAP nuclear localization, co-activator activity and colony formation in pancreatic cancer cells and prevent the initial stages of pancreatic ductal adenocarcinoma in KrasG12D mice
Hao, Fang, Xu, Qinhong, Wang, Jing, Yu, Shuo, Chang, Hui-Hua, Sinnett-Smith, James, Eibl, Guido, Rozengurt, Enrique · 2019 · PLOS ONE
Antitumor activity of curcumin is involved in down-regulation of YAP/TAZ expression in pancreatic cancer cells
Xiuxia Zhou, Jingna Su, Shaoyan Feng, Lixia Wang, Xuyuan Yin, Jingzhe Yan, Zhiwei Peter Wang · 2016 · Oncotarget
RASSF effectors couple diverse RAS subfamily GTPases to the Hippo pathway
Thillaivillalan Dhanaraman, Swati Singh, Ryan C. Killoran, Anamika Singh, Xingjian Xu, Julia M. Shifman, Matthew James Smith · 2020 · Science Signaling
Enhanced YAP expression leads to EGFR TKI resistance in lung adenocarcinomas
Ting‐Fang Lee, Yu-Chi Tseng, Phụng Anh Nguyễn, Yu‐Chuan Li, Chao‐Chi Ho, Cheng-Wen Wu · 2018 · Scientific Reports
Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway
Juwon Jang, Min‐Kyu Kim, Suk‐Chul Bae · 2018 · Small GTPases
Personal Mutanomes Meet Modern Oncology Drug Discovery and Precision Health
Feixiong Cheng, Han Liang, Atul Janardhan Butte, Charis Eng, Ruth Nussinov · 2018 · Pharmacological Reviews
New Insights into YAP/TAZ-TEAD-Mediated Gene Regulation and Biological Processes in Cancer
Yang Zhao, Marisela Sheldon, Yutong Sun, Li Ma · 2023 · Cancers
Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression
Dacheng Xie, Jiujie Cui, Tian Xia, Zhiliang Jia, Liang Wang, Wen-Fei Wei, Anna Zhu, Yong Gao, Keping Xie, Ming Quan · 2015 · Oncotarget
Aurora A kinase activates YAP signaling in triple-negative breast cancer
S.H. Chang, Hirohito Yamaguchi, W Xia, S-O Lim, Yekaterina B. Khotskaya, Yun Wu, W-C Chang, Qinqin Liu, Mien‐Chie Hung · 2016 · Oncogene
Overexpression of Yes Associated Protein 1, an Independent Prognostic Marker in Patients With Pancreatic Ductal Adenocarcinoma, Correlated With Liver Metastasis and Poor Prognosis
María Teresa Salcedo, Jorge Zerón-Medina-Cuairán, Javier Hernández‐Losa, Teresa Mercade Macarulla, J. Balsells, Xavier Merino, Helena Allende, Josep M. Tabernero, Santiago Ramón y Cajal · 2017 · Pancreas
MicroRNA-506 inhibits gastric cancer proliferation and invasion by directly targeting Yap1
Jun Deng, Lei Wan, Xiaojun Xiang, Ling Zhang, Feng Yu, Jun Chen, Feng Miao, Jianping Xiong · 2015 · Tumor Biology
Functional Significance and Therapeutic Potential of miR-15a Mimic in Pancreatic Ductal Adenocarcinoma
Shixiang Guo, Andrew T. Fesler, Wenjie Huang, Yunchao Wang, Jiali Yang, Xianxing Wang, Yao Zheng, Ga‐Ram Hwang, Huaizhi Wang, Jingfang Ju · 2019 · Molecular Therapy — Nucleic Acids
Yap/Taz promote the scavenging of extracellular nutrients through macropinocytosis
Bryan King, Jingwen Araki, Wilhelm Palm, Craig B. Thompson · 2020 · Genes & Development
The Extracellular Niche and Tumor Microenvironment Enhance KRAS Inhibitor Efficacy in Pancreatic Cancer
Vishnu Muthuraj Kumarasamy, Costakis G. Frangou, Jianxin Wang, Yin Wan, Andrew Dynka, Hanna R. Rosenheck, Prasenjit Dey, Ethan V. Abel, Erik S. Knudsen, Agnieszka Katarzyna Witkiewicz · 2024 · Cancer Research
UDP-glucose pyrophosphorylase 2, a regulator of glycogen synthesis and glycosylation, is critical for pancreatic cancer growth
Andrew L. Wolfe, Qingwen Zhou, Eneda Toska, Jacqueline Galeas, Angel A. Ku, Richard P. Koche, Sourav Bandyopadhyay, Maurizio Scaltriti, Carlito B. Lebrilla, Frank P. McCormick et al. · 2021 · Proceedings of the National Academy of Sciences
Mitochondrial dynamics coordinate cell differentiation
Masafumi Noguchi, Atsuko Kasahara · 2017 · Biochemical and Biophysical Research Communications
CRISPR/Cas9-Mediated Knock-Out of KrasG12D Mutated Pancreatic Cancer Cell Lines
Eva Lentsch, Lifei Li, Susanne Pfeffer, Arif Bülent Ekici, Leila Taher, Christian P. Pilarsky, Robert Grützmann · 2019 · International Journal of Molecular Sciences
Genome-wide CRISPR screens of oral squamous cell carcinoma reveal fitness genes in the Hippo pathway
Annie Wai Yeeng Chai, Pei San Yee, Stacey Price, Shi Mun Yee, Hui Mei Lee, Vivian KH Tiong, Emanuel Gonçalves, Fiona M. Behan, Jess Bateson, James G. R. Gilbert et al. · 2020 · eLife
The tumor suppressor RASSF1A induces the YAP1 target gene ANKRD1 that is epigenetically inactivated in human cancers and inhibits tumor growth
Adriana P. Jiménez, Annalena Traum, Thomas Boettger, Holger Hackstein, Antje Maria Richter, Reinhard Dammann · 2017 · Oncotarget
Structure-Based Design of Y-Shaped Covalent TEAD Inhibitors
Wenchao Lu, Mengyang Fan, Wenzhi Ji, Jason Tse, Inchul You, Scott B. Ficarro, Isidoro Tavares, Jianwei Che, Audrey Y. Kim, Xijun Zhu et al. · 2023 · Journal of Medicinal Chemistry
Hippo signaling in stress response and homeostasis maintenance
Beibei Mao, Yuhao Gao, Yujie Bai, Zengqiang Yuan · 2014 · Acta Biochimica et Biophysica Sinica
YAP in pancreatic cancer: oncogenic role and therapeutic strategy
Wenhao Mao, Jia Mai, Hui Peng, Junhu Wan, Ting Sun · 2020 · Theranostics
Role of the YAP Oncoprotein in Priming Ras-Driven Rhabdomyosarcoma
Katherine K. Slemmons, Lisa E.S. Crose, Erin R. Rudzinski, Rex C. Bentley, Corinne Mary Linardic · 2015 · PLoS ONE
Cancer in Drosophila
Héctor Herranz, Teresa Eichenlaub, Stephen Michael Cohen · 2016 · Current topics in developmental biology/Current Topics in Developmental Biology
Role of the Tumor Microenvironment in Regulating Pancreatic Cancer Therapy Resistance
Daiyong Deng, Riya H. Patel, Cheng-Yao Chiang, Pingping Hou · 2022 · Cells
Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Julie Gottlieb Fisher, David L. Tait, Elizabeth S. Garrett-Mayer, Susan Halabi, Pam K. Mangat, Julian C. Schink, Ricardo H. Álvarez, Dan S. Veljovich, Timothy Lewis Cannon, Pamela Ann Crilley et al. · 2020 · Targeted Oncology
Metformin: review of epidemiology and mechanisms of action in pancreatic cancer
Guido Eibl, Enrique Rozengurt · 2021 · Cancer and Metastasis Reviews
Long intergenic non-coding RNA 271 is predictive of a poorer prognosis of papillary thyroid cancer
Ben Ma, Tian Liao, Duo Wen, Chuanpeng Dong, Li Zhou, Shuwen Yang, Yu Wang, Qinghai Ji · 2016 · Scientific Reports
Targeting Hippo signaling in cancer: novel perspectives and therapeutic potential
Liemei Lv, Xiangxiang Zhou · 2023 · MedComm
Melatonin Downregulates PD-L1 Expression and Modulates Tumor Immunity in KRAS-Mutant Non-Small Cell Lung Cancer
Yi‐Chun Chao, Kang‐Yun Lee, Sheng‐Ming Wu, Deng‐Yu Kuo, Pei‐Wei Shueng, Cheng‐Wei Lin · 2021 · International Journal of Molecular Sciences
Hippo Signaling at the Hallmarks of Cancer and Drug Resistance
Ramesh Kumar, Wanjin Hong · 2024 · Cells
Overexpression and biological function of TMEM48 in non-small cell lung carcinoma
Wenliang Qiao, Yudong Han, Wei Jin, Mi Tian, Pei Chung Chen, Jie Min, Haiyang Hu, Binbin Xu, Wenzhuo Zhu, Liwen Xiong et al. · 2015 · Tumor Biology
MiR-497 Suppresses YAP1 and Inhibits Tumor Growth in Non-Small Cell Lung Cancer
Chongbiao Huang, Ruijue Ma, Jie Yue, Na Li, Zengxun Li, Daliang Qi · 2015 · Cellular Physiology and Biochemistry
Targeting plasma membrane phosphatidylserine content to inhibit oncogenic KRAS function
Walaa E. Kattan, Wei Chen, Xiaoping Ma, Tien-Hung Lan, Dharini van der Hoeven, Ransome van der Hoeven, John F. Hancock · 2019 · Life Science Alliance
YAP promotes sorafenib resistance in hepatocellular carcinoma by upregulating survivin
Ting Sun, Wenhao Mao, Hui Peng, Qi Wang, Lin Jiao · 2021 · Cellular Oncology
YAP and the drug resistance highway
Alona Keren‐Paz, Rafi Emmanuel, Yardena Samuels · 2015 · Nature Genetics
Genetic disruption of oncogenic Kras sensitizes lung cancer cells to Fas receptor-mediated apoptosis
Mou, Haiwei, Moore, Jill, Malonia, Sunil K., Li, Yingxiang, Ozata, Deniz M., Hough, Soren, Song, Chun-Qing, Smith, Jordan L., Fischer, Andrew, Weng, Zhiping et al. · 2017 · Proceedings of the National Academy of Sciences
Adaptive and Reversible Resistance to Kras Inhibition in Pancreatic Cancer Cells
Panyu Chen, Mandar Deepak Muzumdar, Kimberly Judith Dorans, Rebecca Robbins, Arjun J. Bhutkar, Amanda M. Del Rosario, Philipp Mertins, Jana Qiao, Claudia Schäfer, Frank B. Gertler et al. · 2017 · Cancer Research
MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional Activity
Raffaela Santoro, Marco Zanotto, Carmine Carbone, Geny Piro, Giampaolo Tortora, Davide Melisi · 2018 · Anticancer Research
Hippo signaling dysfunction induces cancer cell addiction to YAP
Han Han, Bing Yang, Hiroki J. Nakaoka, Jiadong Yang, Yifan Zhao, Kathern Le Nguyen, Amell Taffy Bishara, Tejas Krishen Mandalia, Wenqi Wang · 2018 · Oncogene
PR55α regulatory subunit of PP2A inhibits the MOB1/LATS cascade and activates YAP in pancreatic cancer cells
Ashley L. Hein, Nichole D. Brandquist, Caroline Y. Ouellette, Parthasarathy Seshacharyulu, Charles A. Enke, Michel M. Ouellette, Surinder K. Batra, Ying Yan · 2019 · Oncogenesis
P4HA2-induced prolyl hydroxylation suppresses YAP1-mediated prostate cancer cell migration, invasion, and metastasis
Ming Liang Zhu, Ruiqing Peng, Xin Liang, Zhengdao Lan, Ming Tang, Pingping Hou, Jian H. Song, Celia Sze Ling Mak, Ji‐Won Park, Shui-er Zheng et al. · 2021 · Oncogene
Panobinostat sensitizes KRAS‐mutant non‐small‐cell lung cancer to gefitinib by targeting TAZ
Wen‐Ying Lee, Pin‐Cyuan Chen, Wen‐Shin Wu, Han‐Chung Wu, Chun-Hsin Lan, Yen‐Hua Huang, Chia‐Hsiung Cheng, Ku‐Chung Chen, Cheng‐Wei Lin · 2017 · International Journal of Cancer
HMGB1‐RAGE signaling facilitates Ras‐dependent Yap1 expression to drive colorectal cancer stemness and development
Fei Qian, Jianjia Xiao, Ling Gai, Jianwei Zhu · 2018 · Molecular Carcinogenesis
Small Molecule KRAS Inhibitors: The Future for Targeted Pancreatic Cancer Therapy?
Josef Gillson, Yogambha Ramaswamy, Gurvinder Singh, Alemayehu Abebe Gorfe, Nick Pavlakis, Jaswinder Singh Samra, Anubhav Mittal, Sumit Sahni · 2020 · Cancers
MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic target
Yifei Wang, Huarong Chen, Weixin Liu, Huan Yan, Yihan Zhang, Alvin H.K. Cheung, Jinglin Zhang, Bonan Chen, Liang Li, Zhaocai Zhou et al. · 2022 · Theranostics
The Role of the Microbiome in Pancreatic Cancer
Koji Miyabayashi, Hideaki Ijichi, Mitsuhiro Fujishiro · 2022 · Cancers
Pancreatic cancer: molecular pathogenesis and emerging therapeutic strategies
Enrique Rozengurt, Guido Eibl · 2026 · Signal Transduction and Targeted Therapy
TMEM140 is associated with the prognosis of glioma by promoting cell viability and invasion
Bin Li, Mingzhu Huang, Xiaoqiang Wang, Bangbao Tao, Jun Zhong, Xuhui Wang, Wenchuan Zhang, Shiting Li · 2015 · Journal of Hematology & Oncology
GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
Sandra Baumgart, NM Chen, Jin‐San Zhang, Daniel D. Billadeau, Irina N. Gaisina, Alan P. Kozikowski, Shiv K. Singh, Daniel Fink, Philipp Ströbel, Caroline Klindt et al. · 2016 · Molecular Cancer Therapeutics
Fbxw7 Deletion Accelerates KrasG12D-Driven Pancreatic Tumorigenesis via Yap Accumulation
Qiang Zhang, Yaqing Zhang, Joshua D. Parsels, Ines Lohse, Theodore Steven Lawrence, Marina Pasca di Magliano, Yi Sun, Meredith Ann Morgan · 2016 · Neoplasia
YAP manipulates proliferation via PTEN/AKT/mTOR-mediated autophagy in lung adenocarcinomas
Wei Xu, Mingjiong Zhang, Yue Li, Yu Wang, Kai Wang, Qiaoyu Chen, Runjie Zhang, Weiwei Song, Qiqing Huang, Weihong Zhao et al. · 2021 · Cancer Cell International
Combined KRAS Inhibition and Immune Therapy Generates Durable Complete Responses in an Autochthonous PDAC Model
Yonghong Liu, Jincheng Han, Wen‐Hao Hsu, Kyle A. LaBella, Pingna Deng, Xiaoying Shang, Paulino Tallón de Lara, Li Cai, Shan Jiang, Ronald Anthony DePinho · 2024 · Cancer Discovery
PPARδ Interacts with the Hippo Coactivator YAP1 to Promote SOX9 Expression and Gastric Cancer Progression
Shumei Song, Zhenning Wang, Yuan Li, Lang Ma, Jiankang Jin, Ailing W. Scott, Yan Xu, Jeannelyn Santiano Estrella, Yongxi Song, Bin Liu et al. · 2019 · Molecular Cancer Research
SDCBP promotes pancreatic cancer progression by preventing YAP1 from β-TrCP-mediated proteasomal degradation
Jing Liu, Weiwei Bai, Tianxing Zhou, Yongjie Xie, Bo Yang, Jingyan Sun, Yifei Wang, Xueyang Li, Xupeng Hou, Ziyun Liu et al. · 2023 · Gut
Deciphering mechanical cues in the microenvironment: from non-malignant settings to tumor progression
Yicheng Zhu, Jiaoshun Chen, Chen Chen, Rong Tang, Jin Xu, Si Shi, Xianjun Yu · 2025 · Biomarker Research
A MEK/PI3K/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cells
Irene Ischenko, Oleksi Petrenko, Michael J. Hayman · 2015 · Oncotarget
Principles of K-Ras effector organization and the role of oncogenic K-Ras in cancer initiation through G1 cell cycle deregulation
Ruth Nussinov, Chung‐Jung Tsai, Serena Muratcioğlu, Hyunbum Jang, Attila Gürsoy, Özlem Keskin · 2015 · Expert Review of Proteomics
LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth
Oihane Erice, Shruthi Narayanan, Iker Feliu, Rodrigo Entrialgo‐Cadierno, Antonia Malinova, Caterina Vicentini, Elizabeth Guruceaga, Pietro Delfino, Marija Trajkovic‐Arsic, Haritz Moreno et al. · 2023 · Clinical Cancer Research
Deubiquitylating enzyme USP9x regulates hippo pathway activity by controlling angiomotin protein turnover
Thanh Nguyen, Diāna Andrējeva, Rajat Gupta, Chunaram Choudhary, Xin Hong, Pieter J.A. Eichhorn, Anand C. Loya, Stephen Michael Cohen · 2016 · Cell Discovery
Metformin Decreases the Incidence of Pancreatic Ductal Adenocarcinoma Promoted by Diet-induced Obesity in the Conditional KrasG12D Mouse Model
Hui-Hua Chang, Aune Moro, Caroline Ei Ne Chou, David W. Dawson, Samuel William French, Andrea Schmidt, James W. Sinnett‐Smith, Hao Fang, Oscar Joe Hines, Guido Eibl et al. · 2018 · Scientific Reports
Tolerant/Persister Cancer Cells and the Path to Resistance to Targeted Therapy
Mirna Swayden, Houssein Chhouri, Youssef Anouar, Luca Grumolato · 2020 · Cells
The Hippo effector TAZ ( WWTR1 ) transforms myoblasts and TAZ abundance is associated with reduced survival in embryonal rhabdomyosarcoma
Abdalla D. Mohamed, Congshan Sun, Vanessa De Mello, Joanna Selfe, Edoardo Missiaglia, JANET M. SHIPLEY, Graeme I. Murray, Peter S. Zammit, Henning Wackerhage · 2016 · The Journal of Pathology